Supplementary Materialsoncotarget-06-18707-s001. 61.1%, 52.7%, 55.2%, and 60.4%, respectively. There were no significant differences in survival rates NSC 23766 ic50 between experimental and control groups. However, patients with favorable pathologic responses had improved outcomes compared to those with unfavorable pathologic responses and to those in the control group. Although TPF induction chemotherapy did not improve long-term… Continue reading Supplementary Materialsoncotarget-06-18707-s001. 61.1%, 52.7%, 55.2%, and 60.4%, respectively. There were no